LIVE WEBINAR

Inside Concentriq: The Product Behind the Top KLAS Score

April 28, 2026 | 11am ET | 45 minutes

2026-best-in-klas-digital-pathology-global-europe-800

Digital Pathology Built for Real-World Practice

As digital pathology moves into daily practice, the standard for what a platform should deliver is rising: an experience that works the way pathologists think, operations that grow with the lab, and AI that fits naturally into the workflow.

Proscia built Concentriq to that standard, and continues to evolve it alongside the customers who use it every day. As a result, Proscia's customers told KLAS they trust Concentriq, rating Proscia the top-performing digital pathology vendor across the US¹ and Europe.²

Join Proscia’s product team for a look at how the platform works in practice across academic medical centers, health systems, and reference labs — and a sneak peek at what we're building next. Plus, you'll hear from guest speaker Daniel Roberts, MD, Medical Director of Digital Pathology at Cleveland Clinic, on what digital pathology adoption and change management actually looks like in practice at one of the nation's largest academic medical centers.

Recommended for: Pathology leaders, laboratory operations teams, IT and informatics professionals, and digital pathology leaders evaluating or expanding digital pathology programs.

Speakers

Daniel Roberts
Dr. Daniel Roberts
Medical Director of Digital Pathology, Cleveland Clinic
Amanda Coble, Product Director (2)
Amanda Coble
Senior Director of Product, Proscia
PK
Pradyuman Kodavatiganti
Senior Product Designer, Proscia
Ashley
Ashley Faber
Senior Director of Product Marketing, Proscia

Why Attend?

Dan the Pathologist

Experience the Pathologist-Centric Difference

Watch a demonstration of how Concentriq supports high-volume image review — from the viewing and annotation experience to collaboration across sites — and the customer-driven design decisions behind it.

Hear from a Pathology Leader in Practice

Daniel Roberts, MD, will share his perspective on adopting and scaling digital pathology — what mattered in platform evaluation, what adoption actually looks like, and what he'd tell leaders earlier in their journey.

Learn How to Scale with Enterprise-Ready Operations

See how Concentriq helps your lab scale today and future-proof for tomorrow with an open, vendor-neutral architecture and advanced image management.

See What’s Coming Next

Get an early look at upcoming capabilities designed to reduce administrative burden, give pathologists more control, and unlock new value for laboratories — informed by what we're hearing from customers and where the field is heading.

  1. Digital Pathology 2026: Early Adoption & Technology Performance in an Emerging US Market, February 2026, KLAS Research
  2. 2026 Best in KLAS Awards: Global Software Report
Proscia_Navy_Blue_logo_2

Proscia is rewiring pathology for precision medicine to improve patient outcomes. Its technology fuels the development and use of novel therapies and diagnostics, harnessing data and AI in the fight against humanity’s most challenging diseases, like cancer. 16 of the top 20 pharmaceutical companies rely on these solutions each day, and Proscia was named Global 2026 Best in KLAS for Digital Pathology in Europe. For more information, visit proscia.com and follow Proscia on LinkedIn and X.


© Copyright 2026. Proscia Inc., Proscia, Concentriq, Proscia Aperture, the circles logo and Proscia Aperture logo are trademarks or registered trademarks owned by Proscia Inc. All rights reserved.

Concentriq AP-Dx is FDA-cleared for primary diagnosis in the United States (U.S.) with the Hamamatsu NanoZoomer® S360MD Slide scanner and is licensed in Canada and CE‑marked under the EU IVDR for primary diagnosis. Concentriq AP-Dx is not intended for use with frozen sections, cytology, or non-FFPE hematopathology specimens. Concentriq AP and Concentriq LS are for Research Use Only. Not for use in diagnostic procedures.